Key result
The rs10455872 variant in the LPA gene significantly increased the risk of acute coronary syndrome (OR 2.69), and smoking was found to modify the protective effects of variants in the LDLR and SERPINE1 genes.
Why the study?
Multiple genetic and environmental factors interact in the development of acute coronary syndrome, and smoking might alter metabolic pathways shared by genes associated with this condition.
Do specific genetic variants related to inflammation, lipid metabolism, and platelet aggregation, and their interactions with smoking, increase the risk of acute coronary syndrome?
Case-Control (n=760)
No
Do specific genetic variants related to inflammation, lipid metabolism, and platelet aggregation, and their interactions with smoking, increase the risk of acute coronary syndrome?
Genetic variants in LPA and APOE are associated with increased ACS risk, while variants in LDLR and SERPINE1 demonstrate significant gene-environment interactions with smoking.
Answers are grounded in this paper and cite their sources.
Findings on gene-smoking interactions in ACS are hypothesis-generating; leaves open validation before any risk stratification use.
INTRODUCTION: Multiple genetic and environmental factors interact with the development of acute coronary syndrome. Smoking is one of the environmental factors that might alter the metabolic pathways shared by genes associated with this condition. OBJECTIVE: To investigate the association of acute coronary syndrome with genetic variants related to inflammation, lipid metabolism, and platelet aggregation among subjects from the northeastern region of Colombia. The effects of interactions between polymorphisms and smoking were also evaluated. MATERIALS AND METHODS: We analyzed data from 330 acute coronary syndrome cases and 430 controls. Associations between 20 polymorphisms and acute coronary syndrome were evaluated using logistic regression, adjusting for confounders. Gene and smoking interaction terms were calculated, and variants were analyzed separately in smokers and non-smokers for their association with acute coronary syndrome. RESULTS: Two variants were associated with acute coronary syndrome, rs10455872 in the LPA gene (OR = 2.69; 95% CI: 1.61-4.49) and rs429358 in the APOE gene (OR = 1.93; 95% CI: 1.30-2.87). We identified smoking interactions with the variants rs6511720 in the LDLR gene (p = 0.04) and rs2227631 in the SERPINE1 gene (p = 0.02), with significant effects in non-smokers (rs6511720: OR = 0.40; 95% CI: 0.19-0.88; and rs2227631: OR = 0.69; 95% CI: 0.48-1.00), but not in smokers (rs6511720: OR = 1.28; 95% CI: 0.66-2.46; and rs2227631: OR = 1.30; 95% CI: 0.91-1.87). CONCLUSIONS: Variants in the candidate genes LPA and APOE are associated with an increased risk of acute coronary syndrome in a population from northeastern Colombia. The effects of rs6511720 in LDLR and rs2227631 in SERPINE1 differ according to smoking habits and are significant in non-smokers. These results are helpful for early risk screening of acute coronary syndrome, mainly in individuals without defined conventional risk factors.
No takes yet. Share an insight, caveat, or question.
Franco et al. (2025) conducted a case-control in Acute coronary syndrome (n=760). LPA rs10455872 variant vs. Non-carriers was evaluated on Risk of acute coronary syndrome (OR 2.69, 95% CI 1.61-4.49, p=<0.001). The rs10455872 variant in the LPA gene significantly increased the risk of acute coronary syndrome (OR 2.69), and smoking was found to modify the protective effects of variants in the LDLR and SERPINE1 genes.
Synapse has enriched 10 related papers. Consider them for comparative context: